Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction
Open Access
- 12 April 2022
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 723, 109217
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81974030)
This publication has 38 references indexed in Scilit:
- Triptolide protects rat heart against pressure overload-induced cardiac fibrosisInternational Journal of Cardiology, 2013
- Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart FailureCell Metabolism, 2013
- Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expressionBiochemical Pharmacology, 2013
- MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathwayBiochemical Pharmacology, 2011
- Protective effect of (−)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A histopathological studyBiomedicine & Pharmacotherapy, 2008
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Tea polyphenols for health promotionLife Sciences, 2007
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004
- From genomics to proteomicsNature, 2003
- Fatty acid-binding protein and its relation to fatty acid oxidationMolecular and Cellular Biochemistry, 1993